These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33496313)

  • 21. [Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?].
    Hoogeveen RM; Stroes ESG; Cornel JH
    Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33201620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine and myocardial infarction: A review.
    Akodad M; Sicard P; Fauconnier J; Roubille F
    Arch Cardiovasc Dis; 2020 Oct; 113(10):652-659. PubMed ID: 32712201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine for secondary prevention in coronary disease.
    Fiolet ATL; Nidorf SM; Cornel JH;
    Eur Heart J; 2021 Mar; 42(11):1060-1061. PubMed ID: 33346343
    [No Abstract]   [Full Text] [Related]  

  • 24. Inflammation and ischemic heart disease: The next therapeutic target?
    Vilela EM; Fontes-Carvalho R
    Rev Port Cardiol (Engl Ed); 2021 Oct; 40(10):785-796. PubMed ID: 34857118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for colchicine in secondary prevention of coronary artery disease?
    Sudevan R
    Eur J Prev Cardiol; 2022 Feb; 28(17):1914-1915. PubMed ID: 34219144
    [No Abstract]   [Full Text] [Related]  

  • 26. Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.
    Roubille F; Tardif JC
    Circulation; 2020 Nov; 142(20):1901-1904. PubMed ID: 33196312
    [No Abstract]   [Full Text] [Related]  

  • 27. Time to commence or time out for colchicine in secondary prevention of cardiovascular disease?
    Pradhan AD
    Eur Heart J; 2021 Jul; 42(28):2776-2779. PubMed ID: 33824963
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-inflammatory Drug Combination Therapy for Atherosclerosis: Colchicine and Fenofibrate.
    Spartalis M; Tzima I; Anastasiou A; Spartalis E; Iliopoulos DC; Siasos G
    Curr Med Chem; 2022; 29(26):4477-4480. PubMed ID: 35392778
    [No Abstract]   [Full Text] [Related]  

  • 29. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemic of the 20(th) century: coronary heart disease.
    Dalen JE; Alpert JS; Goldberg RJ; Weinstein RS
    Am J Med; 2014 Sep; 127(9):807-12. PubMed ID: 24811552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colchicine Use in Acute Coronary Syndromes: An Update.
    Tapoi L; Benchea L; Siriopol D; Kanbay M; Covic A
    Angiology; 2021 Jul; 72(6):503-510. PubMed ID: 33412929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining the potential of the influenza vaccine for secondary prevention: a myocardial infarction vaccine?
    Phrommintikul A; Wongcharoen W
    Future Cardiol; 2012 May; 8(3):345-8. PubMed ID: 22642627
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of ticagrelor were similar in patients with past MI, regardless of multivessel coronary disease.
    Goel A
    Ann Intern Med; 2018 May; 168(10):JC56. PubMed ID: 29800432
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    Tardif JC; Kouz S; Waters DD; Bertrand OF; Diaz R; Maggioni AP; Pinto FJ; Ibrahim R; Gamra H; Kiwan GS; Berry C; López-Sendón J; Ostadal P; Koenig W; Angoulvant D; Grégoire JC; Lavoie MA; Dubé MP; Rhainds D; Provencher M; Blondeau L; Orfanos A; L'Allier PL; Guertin MC; Roubille F
    N Engl J Med; 2019 Dec; 381(26):2497-2505. PubMed ID: 31733140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.
    Opstal TSJ; van Broekhoven A; Fiolet ATL; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Budgeon CA; Bartels L; de Nooijer R; Bax WA; Tijssen JGP; El Messaoudi S; Cornel JH
    Circulation; 2022 Feb; 145(8):626-628. PubMed ID: 35188792
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
    Abbasi J
    JAMA; 2020 Apr; 323(13):1233-1234. PubMed ID: 32186687
    [No Abstract]   [Full Text] [Related]  

  • 37. RISK-FACTORS OF CORONARY ARTERY DISEASE (REVIEW).
    Kantaria M; Buleishvili M; Kipiani NV; Ormotsadze G; Sanikidze T
    Georgian Med News; 2020 Feb; (299):78-82. PubMed ID: 32242850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distinct role of secondary prevention in patients with prior coronary interventions.
    Colmenarez H; Escaned J
    EuroIntervention; 2009 May; 5 Suppl D():D131-8. PubMed ID: 19736062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Colchicine Beneficial for the Prevention of Cardiovascular Events After Myocardial Infarction?
    Paul TK; Mukherjee D
    Angiology; 2021 Jul; 72(6):501-502. PubMed ID: 33813881
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions.
    Mehta A; Mahtta D; Gulati M; Sperling LS; Blumenthal RS; Virani SS
    Curr Atheroscler Rep; 2020 Jan; 22(1):3. PubMed ID: 31927694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.